期刊文献+

芎芷煎方治疗偏头痛的临床疗效及机理研究 被引量:9

Therapeutic Effects and Mechanism of“Xiongzhi Decoction”in Treatment of Patients with Migraine
下载PDF
导出
摘要 目的:观察芎芷煎方治疗偏头痛的临床疗效并探讨其作用机制。方法:采取随机、对照方法将122例偏头痛患者分为治疗组62例和对照组60例,治疗组口服中药芎芷煎方,对照组口服西比灵胶囊;2组疗程均为3个月,观察临床疗效和头痛发作频率及头痛程度变化情况以及血液流变学指标和血浆5-羟色胺、降钙素基因相关肽、一氧化氮含量、脑电图的变化。结果:治疗组、对照组临床总有效率分别为78.5%、53.2%,组间疗效比较差异有统计学意义;2组治疗后1个月、2个月及3个月偏头痛发作频率和头痛程度评分均明显降低,组间治疗后同期比较差异有统计学意义,且治疗组血浆5-HT含量较前升高,CGRP、NO含量明显下降,血液流变学指标改善情况和脑电图检查结果与对照组比较差异有统计学意义。结论:芎芷煎方治疗偏头痛具有较好的治疗作用,其作用机理与升高血浆5-HT含量、降低血浆CGRP、NO含量以及改善血液流变学和脑电图改变有关。 Objective: To observe the clinical effects of"Xiongzhi Decoction" on migraine and investigate its mechanism. Methods: Total 122 cases were randomized into two groups: treatment group in which 62 cases were treated with" Xiongzhi Decoction" and control group in which 60 cases were treated with Flunarizine Capsule, with a course of 3months..The clinical efficacy and migraine frequency and severity were observed. Results: The total effective rate was 78.5% in the treatment group and 53.2% in the control group, with a striking difference between them. After treatment, the scores of migraine frequency and severity were reduced in both groups, with a significant difference between the two groups. Compare with the control group that the Plasma 5-HT levels increased, CGRP and NO levels decreased, blood theology and EEG findings to improve at the treatment group, the disparity has significant difference. Conclusion: "Xiongzhi Decoction" is quite effective for migraine. Its mechanism may be relate to the Plasma 5-HT, CGRP and NO levels and blood rheology and EEG.
出处 《中国中医基础医学杂志》 CAS CSCD 北大核心 2016年第2期216-218,233,共4页 JOURNAL OF BASIC CHINESE MEDICINE
基金 江苏省中医药领军人才资助项目(LJ200930) 江苏省"六大人才高峰"高层次人才资助项目(WSN-013)
关键词 偏头痛 中医药疗法 芎芷煎方 Migraine Chinese medicine therapy "Xiongzhi Decoction"
  • 相关文献

参考文献9

  • 1郭述苏,薛广波,王桂清,王笑中,王耀中.中国偏头痛流行病学调查[J].临床神经病学杂志,1991,4(2):65-69. 被引量:109
  • 2Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders : 2nd edition [ J J. Cephalalgia: an international journal of headache,2004,24( ZI ) :9-160.
  • 3全国脑病急症协作组.头风诊断与疗效评定标准[J].山东中医药大学学报,1993,16(5):69.
  • 4Hartrick CT, Koran JP, Shapiro S. The numeric rating scale for clinical pain measurement: a ratio measure? [ J]. Pain Pract,2003, 3(4): 310-316.
  • 5门凌,张洪钦.治偏痛胶囊治疗偏头痛的疗效及对血浆5-羟色胺的影响[J].中国实验方剂学杂志,2013,19(13):336-339. 被引量:24
  • 6Ganji S, Hellman S, Stagg S, et al. Episodic coma due to acute basilar artery migraine: correlation of EEG and brainstem auditory evoked potential patterns [ J ]. Cliu Electroencephalogy, 1993,24( 1 ) :44.
  • 7张兆辉,卫涛涛,余绍祖,等.川芎嗪的抗氧化机制对缺血性脑损伤的保护作用[J].中国组织工程研究与临床康复,2004,8(34):7742-7744.
  • 8陈奇,连晓媛,毕明,陈鹏祥,邓其仕,何运智.蔓荆子开发研究[J].江西中医药,1991,22(1):42-43. 被引量:19
  • 9高崇凯,吴雁,王勇,颜杰,潘华新,曹柳英,梁瑞燕.白芍总苷粉针剂的抗炎、镇痛作用[J].中药新药与临床药理,2002,13(3):163-165. 被引量:95

二级参考文献27

  • 1张鸿炼,吴文蔚.白芍总甙的药理作用与临床应用[J].中国医院药学杂志,1995,15(8):371-372. 被引量:19
  • 2周端求,杨铮铮.牛黄降压胶囊治疗偏头痛的临床观察[J].中国中药杂志,2006,31(10):860-862. 被引量:5
  • 3王忠诚 程学铭 等.中国六城市居民神经系统疾病的流行病学调查[J].中华神经外科杂志,1985,1:2-4.
  • 4徐叔云.药理实验方法,第2版[M].北京:人民卫生出版社,1994.206.
  • 5王永祥 陈敏珠 等.亳白芍芍药总甙的药理作用[J].安徽医科大学学报,1986,21(1):11-11.
  • 6王永祥 陈敏珠 等.白芍总甙的镇痛作用[J].中国药理学与毒理学杂志,1988,2(1):6-9.
  • 7Lipton R B, Stewart W F, Diamond S, et al. Prevalence and burden of migraine in the United States:data from the American Migraine Study II [ J ]. Headache ,2001,41 ( 7 ) :646.
  • 8Menken M, Munsat T L, Toole J F. The global burden of disease study: implications for neurology [ J ]. Arch Neurol,2000,57 ( 3 ) :418.
  • 9Headache classification subconmfittee of the international headaehe societ. The international classsification of headache disorders : 2nd edition [ J ]. Cephalalgia,2004,24 ( Suppl 1 ) :9.
  • 10Steiner T J. Treating headache from an evidence base: the cochrane collaboration [ J]. Cephalalgia, 1998, 18 ( Suppl 21 ) :63.

共引文献238

同被引文献115

引证文献9

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部